Jundishapur Journal of Microbiology

Published by: Kowsar

High Recovery Rate of Non-albicans Candida Species Isolated From Burn Patients With Candidemia in Iran

Nazanin Lotfi 1 , 2 , Tahereh Shokohi 2 , * , Seyed Zahra Nouranibaladezaei 3 , Ayatollah Nasrolahi Omran 1 and Nahid Kondori 4
Authors Information
1 Department of Medical Mycology, Faculty of Medical Sciences, Tonekabon Branch, Islamic Azad University, Tonekabon, IR Iran
2 Department of Medical Mycology and Parasitology, Invasive Fungi Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
3 Burn Center, Zare Hospital, Mazandaran University of Medical Sciences, Sari, IR Iran
4 Department of Infectious Disease, University of Gothenburg, Gothenburg, Sweden
Article information
  • Jundishapur Journal of Microbiology: October 01, 2015, 8 (10); e22929
  • Published Online: October 24, 2015
  • Article Type: Research Article
  • Received: August 19, 2014
  • Revised: January 29, 2015
  • Accepted: February 24, 2015
  • DOI: 10.5812/jjm.22929

To Cite: Lotfi N, Shokohi T, Nouranibaladezaei S Z, Nasrolahi Omran A, Kondori N. High Recovery Rate of Non-albicans Candida Species Isolated From Burn Patients With Candidemia in Iran, Jundishapur J Microbiol. 2015 ; 8(10):e22929. doi: 10.5812/jjm.22929.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Holzheimer RG, Dralle H. Management of mycoses in surgical patients -- review of the literature. Eur J Med Res. 2002; 7(5): 200-26[PubMed]
  • 2. Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect. 2003; 53(1): 6-13[PubMed]
  • 3. Cochran A, Morris SE, Edelman LS, Saffle JR. Systemic Candida infection in burn patients: a case-control study of management patterns and outcomes. Surg Infect (Larchmt). 2002; 3(4): 367-74[DOI][PubMed]
  • 4. Murray CK, Loo FL, Hospenthal DR, Cancio LC, Jones JA, Kim SH, et al. Incidence of systemic fungal infection and related mortality following severe burns. Burns. 2008; 34(8): 1108-12[DOI][PubMed]
  • 5. Tortorano AM, Dho G, Prigitano A, Breda G, Grancini A, Emmi V, et al. Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008). Mycoses. 2012; 55(1): 73-9[DOI][PubMed]
  • 6. Ha JF, Italiano CM, Heath CH, Shih S, Rea S, Wood FM. Candidemia and invasive candidiasis: a review of the literature for the burns surgeon. Burns. 2011; 37(2): 181-95[DOI][PubMed]
  • 7. Wu J, Xie S, Zhang G, Zhan J, Xie W, Yu R, et al. Guideline for diagnosis, prophylaxis and treatment of invasive fungal infection post burn injury in China 2013. Burns & Trauma. 2014; 2(2): 45[DOI]
  • 8. Macphail GL, Taylor GD, Buchanan-Chell M, Ross C, Wilson S, Kureishi A. Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals. Mycoses. 2002; 45(5-6): 141-5[PubMed]
  • 9. Ghahri M, Mirhendi H, Zomorodian K, Kondori N. Identification and Antifungal Susceptibility Patterns of Candida Strains Isolated From Blood Specimens in Iran. Arch Clin Infect Dis. 2013; 8
  • 10. Girmenia C, Tuccinardi C, Santilli S, Mondello F, Monaco M, Cassone A, et al. In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies. J Antimicrob Chemother. 2000; 46(3): 479-83[PubMed]
  • 11. Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med. 2009; 37(5): 1612-8[DOI][PubMed]
  • 12. Tumbarello M, Sanguinetti M, Trecarichi EM, La Sorda M, Rossi M, de Carolis E, et al. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome. J Antimicrob Chemother. 2008; 62(6): 1379-85[DOI][PubMed]
  • 13. Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One. 2011; 6(9)[DOI][PubMed]
  • 14. Kiehn TE, Capitolo C, Mayo JB, Armstrong D. Comparative recovery of fungi from biphasic and conventional blood culture media. J Clin Microbiol. 1981; 14(6): 681-3[PubMed]
  • 15. Moore EC, Padiglione AA, Wasiak J, Paul E, Cleland H. Candida in burns: risk factors and outcomes. J Burn Care Res. 2010; 31(2): 257-63[DOI][PubMed]
  • 16. Espinel-Ingroff A, Pfaller M, Erwin ME, Jones RN. Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose. J Clin Microbiol. 1996; 34(4): 848-52[PubMed]
  • 17. Raz-Pasteur A, Hussein K, Finkelstein R, Ullmann Y, Egozi D. Blood stream infections (BSI) in severe burn patients--early and late BSI: a 9-year study. Burns. 2013; 39(4): 636-42[DOI][PubMed]
  • 18. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004; 39(3): 309-17[DOI][PubMed]
  • 19. Zorgani A, Franka RA, Zaidi MM, Alshweref UM, Elgmati M. Trends in nosocomial bloodstream infections in a burn intensive care unit: an eight-year survey. Ann Burns Fire Disasters. 2010; 23(2): 88-94[PubMed]
  • 20. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002; 50(4): 243-60[DOI][PubMed]
  • 21. Nicholson A, Rainford L. The epidemiology of fungaemia at the University Hospital of the West Indies, Kingston, Jamaica. West Indian Med J. 2009; 58(6): 580-4[PubMed]
  • 22. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP, National Nosocomial Infections Surveillance System H. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis. 2002; 35(5): 627-30[DOI][PubMed]
  • 23. Miranda LN, van der Heijden IM, Costa SF, Sousa AP, Sienra RA, Gobara S, et al. Candida colonisation as a source for candidaemia. J Hosp Infect. 2009; 72(1): 9-16[DOI][PubMed]
  • 24. Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008; 21(4): 606-25[DOI][PubMed]
  • 25. Yildirim M, Sahin I, Kucukbayrak A, Ozdemir D, Tevfik Yavuz M, Oksuz S, et al. Hand carriage of Candida species and risk factors in hospital personnel. Mycoses. 2007; 50(3): 189-92[DOI][PubMed]
  • 26. Sheridan RL, Weber JM, Budkevich LG, Tompkins RG. Candidemia in the pediatric patient with burns. J Burn Care Rehabil. 1995; 16(4): 440-3[PubMed]
  • 27. Shorr AF, Chung K, Jackson WL, Waterman PE, Kollef MH. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med. 2005; 33(9): 1928-35[PubMed]
  • 28. Aydin F, Bayramoglu G, Guler NC, Kaklikkaya N, Tosun I. Bloodstream yeast infections in a university hospital in Northeast Turkey: a 4-year survey. Med Mycol. 2011; 49(3): 316-9[DOI][PubMed]
  • 29. Canton E, Espinel-Ingroff A, Peman J, del Castillo L. In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies. Antimicrob Agents Chemother. 2010; 54(5): 2194-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments